Condition: Pneumococcal Disease, Invasive · Pneumococcal Disease · Sponsor: GPN Vaccines
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
This description comes directly from the study's public registry record.
Nerissa Lakhan, PhD · +61-432 161 783 · nerissa@gpnvaccines.com
Paul E Rolan, MD · +61-405 670 420 · paul@gpnvaccines.com
Always discuss trial participation with your own doctor first.
| University of Adelaide Clinical Research Facility | Adelaide, South Australia, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07205289